ID   STAR3_HUMAN             Reviewed;         445 AA.
AC   Q14849; A8MXA4; B4DUY1; F5H0G2; Q53Y53; Q96HM9;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   28-JUN-2023, entry version 204.
DE   RecName: Full=StAR-related lipid transfer protein 3 {ECO:0000305};
DE   AltName: Full=Metastatic lymph node gene 64 protein {ECO:0000303|PubMed:11053434};
DE            Short=MLN 64 {ECO:0000303|PubMed:11053434};
DE   AltName: Full=Protein CAB1 {ECO:0000303|PubMed:9270027};
DE   AltName: Full=START domain-containing protein 3 {ECO:0000303|PubMed:21322544};
DE            Short=StARD3 {ECO:0000303|PubMed:21322544};
GN   Name=STARD3 {ECO:0000312|HGNC:HGNC:17579};
GN   Synonyms=CAB1 {ECO:0000303|PubMed:9270027}, MLN64
GN   {ECO:0000303|PubMed:11053434};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLN-117.
RC   TISSUE=Mammary carcinoma;
RX   PubMed=7490069; DOI=10.1006/geno.1995.1163;
RA   Tomasetto C.L., Regnier C.H., Moog-Lutz C., Mattei M.-G., Chenard M.-P.,
RA   Lidereau R., Basset P., Rio M.-C.;
RT   "Identification of four novel human genes amplified and overexpressed in
RT   breast carcinoma and localized to the q11-q21.3 region of chromosome 17.";
RL   Genomics 28:367-376(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLN-117.
RC   TISSUE=Esophageal carcinoma;
RX   PubMed=9270027;
RA   Akiyama N., Sasaki H., Ishizuka T., Kishi T., Sakamoto H., Onda M.,
RA   Hirai H., Yazaki Y., Sugimura T., Terada M.;
RT   "Isolation of a candidate gene, CAB1, for cholesterol transport to
RT   mitochondria from the c-ERBB-2 amplicon by a modified cDNA selection
RT   method.";
RL   Cancer Res. 57:3548-3553(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLN-117.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANT
RP   GLN-117.
RC   TISSUE=Placenta, and Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS GLN-117
RP   AND ALA-216.
RC   TISSUE=Lung, Skin, and Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY, DOMAIN, AND MUTAGENESIS OF
RP   66-LEU-LEU-67; TYR-89; TYR-113; ASN-219 AND ASN-311.
RX   PubMed=11053434; DOI=10.1074/jbc.m006279200;
RA   Alpy F., Stoeckel M.-E., Dierich A., Escola J.-M., Wendling C.,
RA   Chenard M.-P., Vanier M.T., Gruenberg J., Tomasetto C., Rio M.-C.;
RT   "The steroidogenic acute regulatory protein homolog MLN64, a late endosomal
RT   cholesterol-binding protein.";
RL   J. Biol. Chem. 276:4261-4269(2001).
RN   [8]
RP   FUNCTION.
RX   PubMed=12070139; DOI=10.1074/jbc.m200003200;
RA   Zhang M., Liu P., Dwyer N.K., Christenson L.K., Fujimoto T., Martinez F.,
RA   Comly M., Hanover J.A., Blanchette-Mackie E.J., Strauss J.F. III;
RT   "MLN64 mediates mobilization of lysosomal cholesterol to steroidogenic
RT   mitochondria.";
RL   J. Biol. Chem. 277:33300-33310(2002).
RN   [9]
RP   SUBUNIT, INTERACTION WITH STARD3NL, AND DOMAIN.
RX   PubMed=15718238; DOI=10.1074/jbc.m500723200;
RA   Alpy F., Latchumanan V.K., Kedinger V., Janoshazi A., Thiele C.,
RA   Wendling C., Rio M.C., Tomasetto C.;
RT   "Functional characterization of the MENTAL domain.";
RL   J. Biol. Chem. 280:17945-17952(2005).
RN   [10]
RP   FUNCTION.
RX   PubMed=15930133; DOI=10.1091/mbc.e04-12-1105;
RA   Hoelttae-Vuori M., Alpy F., Tanhuanpaeae K., Jokitalo E., Mutka A.L.,
RA   Ikonen E.;
RT   "MLN64 is involved in actin-mediated dynamics of late endocytic
RT   organelles.";
RL   Mol. Biol. Cell 16:3873-3886(2005).
RN   [11]
RP   SUBCELLULAR LOCATION, SUBUNIT, INTERACTION WITH STARD3NL, AND DOMAIN.
RX   PubMed=16709157; DOI=10.1042/bst0340343;
RA   Alpy F., Tomasetto C.;
RT   "MLN64 and MENTHO, two mediators of endosomal cholesterol transport.";
RL   Biochem. Soc. Trans. 34:343-345(2006).
RN   [12]
RP   3D-STRUCTURE MODELING.
RX   PubMed=16990645; DOI=10.1194/jlr.m600232-jlr200;
RA   Murcia M., Faraldo-Gomez J.D., Maxfield F.R., Roux B.;
RT   "Modeling the structure of the StART domains of MLN64 and StAR proteins in
RT   complex with cholesterol.";
RL   J. Lipid Res. 47:2614-2630(2006).
RN   [13]
RP   FUNCTION.
RX   PubMed=19965586; DOI=10.1194/jlr.m002345;
RA   Charman M., Kennedy B.E., Osborne N., Karten B.;
RT   "MLN64 mediates egress of cholesterol from endosomes to mitochondria in the
RT   absence of functional Niemann-Pick Type C1 protein.";
RL   J. Lipid Res. 51:1023-1034(2010).
RN   [14]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=21322544; DOI=10.1021/bi101906y;
RA   Li B., Vachali P., Frederick J.M., Bernstein P.S.;
RT   "Identification of StARD3 as a lutein-binding protein in the macula of the
RT   primate retina.";
RL   Biochemistry 50:2541-2549(2011).
RN   [15]
RP   FUNCTION.
RX   PubMed=22514632; DOI=10.1371/journal.pone.0034424;
RA   Liapis A., Chen F.W., Davies J.P., Wang R., Ioannou Y.A.;
RT   "MLN64 transport to the late endosome is regulated by binding to 14-3-3 via
RT   a non-canonical binding site.";
RL   PLoS ONE 7:E34424-E34424(2012).
RN   [16]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH VAPA AND VAPB, MUTAGENESIS
RP   OF 206-GLN--GLU-211, FFAT MOTIF, AND DOMAIN.
RX   PubMed=24105263; DOI=10.1242/jcs.139295;
RA   Alpy F., Rousseau A., Schwab Y., Legueux F., Stoll I., Wendling C.,
RA   Spiegelhalter C., Kessler P., Mathelin C., Rio M.C., Levine T.P.,
RA   Tomasetto C.;
RT   "STARD3 or STARD3NL and VAP form a novel molecular tether between late
RT   endosomes and the ER.";
RL   J. Cell Sci. 126:5500-5512(2013).
RN   [17]
RP   INDUCTION.
RX   PubMed=27679500; DOI=10.1007/s13238-016-0315-0;
RA   Pinto J.B., Graham A.;
RT   "The role of endosomal cholesterol trafficking protein, StAR-related lipid
RT   transfer domain 3 (StarD3/MLN64), in BRIN-BD11 insulinoma cells.";
RL   Protein Cell 7:833-838(2016).
RN   [18]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH VAPA AND VAPB,
RP   LIPID-BINDING, AND MUTAGENESIS OF 207-PHE-TYR-208 AND 307-MET--ASN-311.
RX   PubMed=28377464; DOI=10.15252/embj.201695917;
RA   Wilhelm L.P., Wendling C., Vedie B., Kobayashi T., Chenard M.P.,
RA   Tomasetto C., Drin G., Alpy F.;
RT   "STARD3 mediates endoplasmic reticulum-to-endosome cholesterol transport at
RT   membrane contact sites.";
RL   EMBO J. 36:1412-1433(2017).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH MOSPD2, SUBCELLULAR
RP   LOCATION, DOMAIN, FFAT MOTIF, AND MUTAGENESIS OF 207-PHE-TYR-208.
RX   PubMed=29858488; DOI=10.15252/embr.201745453;
RA   Di Mattia T., Wilhelm L.P., Ikhlef S., Wendling C., Spehner D., Nomine Y.,
RA   Giordano F., Mathelin C., Drin G., Tomasetto C., Alpy F.;
RT   "Identification of MOSPD2, a novel scaffold for endoplasmic reticulum
RT   membrane contact sites.";
RL   EMBO Rep. 19:0-0(2018).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 216-445.
RX   PubMed=10802740; DOI=10.1038/75192;
RA   Tsujishita Y., Hurley J.H.;
RT   "Structure and lipid transport mechanism of a StAR-related domain.";
RL   Nat. Struct. Biol. 7:408-414(2000).
RN   [21] {ECO:0007744|PDB:5I9J}
RP   X-RAY CRYSTALLOGRAPHY (1.74 ANGSTROMS) OF 216-444.
RX   PubMed=27487925; DOI=10.1107/s2053230x16010694;
RA   Horvath M.P., George E.W., Tran Q.T., Baumgardner K., Zharov G., Lee S.,
RA   Sharifzadeh H., Shihab S., Mattinson T., Li B., Bernstein P.S.;
RT   "Structure of the lutein-binding domain of human StARD3 at 1.74A resolution
RT   and model of a complex with lutein.";
RL   Acta Crystallogr. F 72:609-618(2016).
CC   -!- FUNCTION: Sterol-binding protein that mediates cholesterol transport
CC       from the endoplasmic reticulum to endosomes (PubMed:11053434,
CC       PubMed:15930133, PubMed:22514632, PubMed:28377464). Creates contact
CC       site between the endoplasmic reticulum and late endosomes: localizes to
CC       late endosome membranes and contacts the endoplasmic reticulum via
CC       interaction with VAPA and VAPB (PubMed:24105263, PubMed:28377464). Acts
CC       as a lipid transfer protein that redirects sterol to the endosome at
CC       the expense of the cell membrane and favors membrane formation inside
CC       endosomes (PubMed:28377464). May also mediate cholesterol transport
CC       between other membranes, such as mitochondria membrane or cell membrane
CC       (PubMed:12070139, PubMed:19965586). However, such results need
CC       additional experimental evidences; probably mainly mediates cholesterol
CC       transport from the endoplasmic reticulum to endosomes
CC       (PubMed:28377464). Does not activate transcriptional cholesterol
CC       sensing (PubMed:28377464). Able to bind other lipids, such as lutein, a
CC       xanthophyll carotenoids that form the macular pigment of the retina
CC       (PubMed:21322544). {ECO:0000269|PubMed:11053434,
CC       ECO:0000269|PubMed:12070139, ECO:0000269|PubMed:15930133,
CC       ECO:0000269|PubMed:19965586, ECO:0000269|PubMed:21322544,
CC       ECO:0000269|PubMed:22514632, ECO:0000269|PubMed:24105263,
CC       ECO:0000269|PubMed:28377464}.
CC   -!- SUBUNIT: Homodimer (PubMed:15718238, PubMed:16709157). Interacts (via
CC       the MENTAL domain) with STARD3NL (PubMed:15718238, PubMed:16709157).
CC       Interacts (via FFAT motif) with VAPA (PubMed:24105263,
CC       PubMed:28377464). Interacts (via FFAT motif) with VAPB
CC       (PubMed:24105263, PubMed:28377464). Interacts (via FFAT motif) with
CC       MOSPD2 (via MSP domain) (PubMed:29858488).
CC       {ECO:0000269|PubMed:15718238, ECO:0000269|PubMed:16709157,
CC       ECO:0000269|PubMed:24105263, ECO:0000269|PubMed:28377464,
CC       ECO:0000269|PubMed:29858488}.
CC   -!- INTERACTION:
CC       Q14849; Q13520: AQP6; NbExp=3; IntAct=EBI-9819324, EBI-13059134;
CC       Q14849; Q9HD26: GOPC; NbExp=3; IntAct=EBI-9819324, EBI-349832;
CC       Q14849; Q8NHP6: MOSPD2; NbExp=6; IntAct=EBI-9819324, EBI-2812848;
CC       Q14849; Q96K19-5: RNF170; NbExp=3; IntAct=EBI-9819324, EBI-12055631;
CC       Q14849-1; Q9P0L0: VAPA; NbExp=4; IntAct=EBI-9819369, EBI-1059156;
CC   -!- SUBCELLULAR LOCATION: Late endosome membrane
CC       {ECO:0000269|PubMed:11053434, ECO:0000269|PubMed:16709157,
CC       ECO:0000269|PubMed:24105263, ECO:0000269|PubMed:28377464,
CC       ECO:0000269|PubMed:29858488}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Localizes to contact sites between the endoplasmic
CC       reticulum and late endosomes: associates with the endoplasmic reticulum
CC       membrane via interaction with VAPA, VAPB or MOSPD2.
CC       {ECO:0000269|PubMed:24105263, ECO:0000269|PubMed:29858488}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q14849-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14849-2; Sequence=VSP_042710;
CC       Name=3;
CC         IsoId=Q14849-3; Sequence=VSP_045361;
CC   -!- TISSUE SPECIFICITY: Expressed in retina. {ECO:0000269|PubMed:21322544}.
CC   -!- INDUCTION: Not regulated by increases in total cholesterol content, or
CC       by marked alterations in cholesterol flux.
CC       {ECO:0000269|PubMed:27679500}.
CC   -!- DOMAIN: The FFAT motif mediates interaction with VAPA, VAPB and MOSPD2.
CC       {ECO:0000269|PubMed:24105263, ECO:0000269|PubMed:29858488}.
CC   -!- DOMAIN: The START domain mediates lipid-transfer between membranes. It
CC       contains a hydrophobic cavity able to accommodate one lipid molecule,
CC       thereby serving as a 'hydrophobic bridge' across the aqueous gap
CC       between donor and acceptor organelle membranes.
CC       {ECO:0000305|PubMed:28377464}.
CC   -!- DOMAIN: The MENTAL domain anchors the protein in endosome membranes and
CC       exposes the START domain in the cytosol (PubMed:11053434). It binds
CC       cholesterol and mediates homotypic as well as heterotypic interactions
CC       between STARD3 and STARD3NL (PubMed:15718238, PubMed:16709157).
CC       {ECO:0000269|PubMed:11053434, ECO:0000269|PubMed:15718238,
CC       ECO:0000269|PubMed:16709157}.
CC   -!- SIMILARITY: Belongs to the STARD3 family. {ECO:0000305}.
CC   -!- CAUTION: STARD3 was reported to function in cholesterol transport to
CC       the mitochondria or to the cell membrane (PubMed:12070139,
CC       PubMed:19965586). Other reports however showed that it mediates
CC       cholesterol transport from the endoplasmic reticulum to endosomes
CC       (PubMed:11053434, PubMed:28377464). Discrepancies may be due to the
CC       different cell type used and the cellular physiological state
CC       (PubMed:28377464). {ECO:0000269|PubMed:11053434,
CC       ECO:0000269|PubMed:12070139, ECO:0000269|PubMed:19965586,
CC       ECO:0000269|PubMed:28377464}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/202/MLN64";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X80198; CAA56489.1; -; mRNA.
DR   EMBL; D38255; BAA22525.1; -; mRNA.
DR   EMBL; BT006964; AAP35610.1; -; mRNA.
DR   EMBL; AK300176; BAG61955.1; -; mRNA.
DR   EMBL; AK300842; BAG62493.1; -; mRNA.
DR   EMBL; AC087491; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC008356; AAH08356.1; -; mRNA.
DR   EMBL; BC008747; AAH08747.1; -; mRNA.
DR   EMBL; BC025679; AAH25679.1; -; mRNA.
DR   CCDS; CCDS11341.1; -. [Q14849-1]
DR   CCDS; CCDS54117.1; -. [Q14849-3]
DR   CCDS; CCDS54118.1; -. [Q14849-2]
DR   PIR; I38027; I38027.
DR   RefSeq; NP_001159409.1; NM_001165937.1. [Q14849-3]
DR   RefSeq; NP_001159410.1; NM_001165938.1. [Q14849-2]
DR   RefSeq; NP_006795.3; NM_006804.3. [Q14849-1]
DR   RefSeq; XP_016879530.1; XM_017024041.1. [Q14849-1]
DR   PDB; 1EM2; X-ray; 2.20 A; A=216-444.
DR   PDB; 5I9J; X-ray; 1.74 A; A=216-444.
DR   PDB; 6TQR; X-ray; 1.85 A; E/F=200-216.
DR   PDB; 6TQU; X-ray; 2.40 A; C/D=196-216.
DR   PDBsum; 1EM2; -.
DR   PDBsum; 5I9J; -.
DR   PDBsum; 6TQR; -.
DR   PDBsum; 6TQU; -.
DR   AlphaFoldDB; Q14849; -.
DR   SMR; Q14849; -.
DR   BioGRID; 116148; 96.
DR   IntAct; Q14849; 19.
DR   STRING; 9606.ENSP00000337446; -.
DR   BindingDB; Q14849; -.
DR   ChEMBL; CHEMBL4523297; -.
DR   SwissLipids; SLP:000000712; -.
DR   TCDB; 9.B.64.1.1; the putative cholesterol transporter (start1) family.
DR   iPTMnet; Q14849; -.
DR   MetOSite; Q14849; -.
DR   PhosphoSitePlus; Q14849; -.
DR   BioMuta; STARD3; -.
DR   DMDM; 116242802; -.
DR   EPD; Q14849; -.
DR   jPOST; Q14849; -.
DR   MassIVE; Q14849; -.
DR   MaxQB; Q14849; -.
DR   PaxDb; Q14849; -.
DR   PeptideAtlas; Q14849; -.
DR   ProteomicsDB; 25332; -.
DR   ProteomicsDB; 60208; -. [Q14849-1]
DR   ProteomicsDB; 60209; -. [Q14849-2]
DR   Antibodypedia; 28306; 97 antibodies from 22 providers.
DR   DNASU; 10948; -.
DR   Ensembl; ENST00000336308.10; ENSP00000337446.5; ENSG00000131748.16. [Q14849-1]
DR   Ensembl; ENST00000394250.8; ENSP00000377794.4; ENSG00000131748.16. [Q14849-2]
DR   Ensembl; ENST00000544210.6; ENSP00000439869.2; ENSG00000131748.16. [Q14849-3]
DR   GeneID; 10948; -.
DR   KEGG; hsa:10948; -.
DR   MANE-Select; ENST00000336308.10; ENSP00000337446.5; NM_006804.4; NP_006795.3.
DR   UCSC; uc002hsd.4; human. [Q14849-1]
DR   AGR; HGNC:17579; -.
DR   CTD; 10948; -.
DR   DisGeNET; 10948; -.
DR   GeneCards; STARD3; -.
DR   HGNC; HGNC:17579; STARD3.
DR   HPA; ENSG00000131748; Low tissue specificity.
DR   MIM; 607048; gene.
DR   neXtProt; NX_Q14849; -.
DR   OpenTargets; ENSG00000131748; -.
DR   PharmGKB; PA134981867; -.
DR   VEuPathDB; HostDB:ENSG00000131748; -.
DR   eggNOG; KOG3845; Eukaryota.
DR   GeneTree; ENSGT00940000159051; -.
DR   HOGENOM; CLU_033480_0_0_1; -.
DR   InParanoid; Q14849; -.
DR   OMA; NQMGLDC; -.
DR   OrthoDB; 3740290at2759; -.
DR   PhylomeDB; Q14849; -.
DR   TreeFam; TF313869; -.
DR   PathwayCommons; Q14849; -.
DR   Reactome; R-HSA-196108; Pregnenolone biosynthesis.
DR   SignaLink; Q14849; -.
DR   BioGRID-ORCS; 10948; 20 hits in 1150 CRISPR screens.
DR   ChiTaRS; STARD3; human.
DR   EvolutionaryTrace; Q14849; -.
DR   GenomeRNAi; 10948; -.
DR   Pharos; Q14849; Tbio.
DR   PRO; PR:Q14849; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q14849; protein.
DR   Bgee; ENSG00000131748; Expressed in right lung and 172 other tissues.
DR   ExpressionAtlas; Q14849; baseline and differential.
DR   Genevisible; Q14849; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0140284; C:endoplasmic reticulum-endosome membrane contact site; IDA:UniProtKB.
DR   GO; GO:0005768; C:endosome; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0031902; C:late endosome membrane; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; HDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0044232; C:organelle membrane contact site; IDA:UniProtKB.
DR   GO; GO:0015485; F:cholesterol binding; IDA:UniProtKB.
DR   GO; GO:0120020; F:cholesterol transfer activity; IEA:InterPro.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0008203; P:cholesterol metabolic process; TAS:ProtInc.
DR   GO; GO:0030301; P:cholesterol transport; IDA:UniProtKB.
DR   GO; GO:0006629; P:lipid metabolic process; TAS:ProtInc.
DR   GO; GO:0006839; P:mitochondrial transport; TAS:ProtInc.
DR   GO; GO:0006701; P:progesterone biosynthetic process; IEA:Ensembl.
DR   GO; GO:0008202; P:steroid metabolic process; TAS:ProtInc.
DR   GO; GO:0099044; P:vesicle tethering to endoplasmic reticulum; IDA:UniProtKB.
DR   CDD; cd08906; START_STARD3-like; 1.
DR   DisProt; DP02835; -.
DR   Gene3D; 3.30.530.20; -; 1.
DR   InterPro; IPR019498; MENTAL.
DR   InterPro; IPR000799; StAR-like.
DR   InterPro; IPR029867; STARD3_MLN64_C.
DR   InterPro; IPR023393; START-like_dom_sf.
DR   InterPro; IPR002913; START_lipid-bd_dom.
DR   PANTHER; PTHR46121:SF2; STAR-RELATED LIPID TRANSFER PROTEIN 3; 1.
DR   PANTHER; PTHR46121; STEROIDOGENIC ACUTE REGULATORY PROTEIN-LIKE; 1.
DR   Pfam; PF10457; MENTAL; 1.
DR   Pfam; PF01852; START; 1.
DR   PRINTS; PR00978; STARPROTEIN.
DR   SMART; SM00234; START; 1.
DR   SUPFAM; SSF55961; Bet v1-like; 1.
DR   PROSITE; PS51439; MENTAL; 1.
DR   PROSITE; PS50848; START; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Endosome; Lipid transport;
KW   Lipid-binding; Membrane; Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..445
FT                   /note="StAR-related lipid transfer protein 3"
FT                   /id="PRO_0000220653"
FT   TOPO_DOM        1..51
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:11053434"
FT   TRANSMEM        52..72
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00770"
FT   TOPO_DOM        73..94
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        95..115
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00770"
FT   TOPO_DOM        116..120
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        121..141
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00770"
FT   TOPO_DOM        142..148
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        149..169
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00770"
FT   TOPO_DOM        170..445
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:11053434"
FT   DOMAIN          46..217
FT                   /note="MENTAL"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00770"
FT   DOMAIN          230..443
FT                   /note="START"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00197"
FT   MOTIF           207..212
FT                   /note="FFAT"
FT                   /evidence="ECO:0000269|PubMed:24105263,
FT                   ECO:0000269|PubMed:29858488"
FT   MOD_RES         209
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61542"
FT   MOD_RES         217
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61542"
FT   MOD_RES         221
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61542"
FT   VAR_SEQ         122..183
FT                   /note="WVIAVTTLVSSAFLIVKVILSELLSKGAFGYLLPIVSFVLAWLETWFLDFKV
FT                   LPQEAEEERW -> SRRWCPVHSSLSRSSSLSCSAKGHLATCSPSSLLSSPGWRPGSLT
FT                   SKSYPRKLKRSDSAPPG (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045361"
FT   VAR_SEQ         126..143
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042710"
FT   VARIANT         117
FT                   /note="R -> Q (in dbSNP:rs1877031)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:7490069,
FT                   ECO:0000269|PubMed:9270027, ECO:0000269|Ref.3"
FT                   /id="VAR_027877"
FT   VARIANT         216
FT                   /note="G -> A (in dbSNP:rs11556624)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_027878"
FT   MUTAGEN         66..67
FT                   /note="LL->AS: Abolishes localization to late endosomes and
FT                   leads to mislocalization to the endoplasmic reticulum."
FT                   /evidence="ECO:0000269|PubMed:11053434"
FT   MUTAGEN         89
FT                   /note="Y->V: Abolishes localization to late endosomes and
FT                   leads to mislocalization to the endoplasmic reticulum."
FT                   /evidence="ECO:0000269|PubMed:11053434"
FT   MUTAGEN         113
FT                   /note="Y->A: Does not affect localization to late
FT                   endosomes."
FT                   /evidence="ECO:0000269|PubMed:11053434"
FT   MUTAGEN         206..212
FT                   /note="Missing: Abolishes interaction with VAPA and VAPB,
FT                   thereby preventing contact with the endoplasmic reticulum
FT                   membrane."
FT                   /evidence="ECO:0000269|PubMed:24105263"
FT   MUTAGEN         207..208
FT                   /note="FY->AA: Abolishes interaction with VAPA, VAPB and
FT                   MOSPD2, thereby preventing contact with the endoplasmic
FT                   reticulum membrane. Abolishes cholesterol accumulation in
FT                   endosomes."
FT                   /evidence="ECO:0000269|PubMed:28377464,
FT                   ECO:0000269|PubMed:29858488"
FT   MUTAGEN         219
FT                   /note="N->A: Does not affect localization to late
FT                   endosomes."
FT                   /evidence="ECO:0000269|PubMed:11053434"
FT   MUTAGEN         307..311
FT                   /note="MVLWN->NVLWD: Abolishes ability to transfer
FT                   cholesterol between membranes."
FT                   /evidence="ECO:0000269|PubMed:28377464"
FT   MUTAGEN         311
FT                   /note="N->A: Does not affect localization to late
FT                   endosomes."
FT                   /evidence="ECO:0000269|PubMed:11053434"
FT   HELIX           233..254
FT                   /evidence="ECO:0007829|PDB:5I9J"
FT   HELIX           255..258
FT                   /evidence="ECO:0007829|PDB:5I9J"
FT   STRAND          260..264
FT                   /evidence="ECO:0007829|PDB:5I9J"
FT   STRAND          270..276
FT                   /evidence="ECO:0007829|PDB:5I9J"
FT   TURN            277..279
FT                   /evidence="ECO:0007829|PDB:5I9J"
FT   STRAND          280..291
FT                   /evidence="ECO:0007829|PDB:5I9J"
FT   HELIX           293..300
FT                   /evidence="ECO:0007829|PDB:5I9J"
FT   HELIX           304..310
FT                   /evidence="ECO:0007829|PDB:5I9J"
FT   STRAND          314..323
FT                   /evidence="ECO:0007829|PDB:5I9J"
FT   TURN            324..326
FT                   /evidence="ECO:0007829|PDB:5I9J"
FT   STRAND          327..334
FT                   /evidence="ECO:0007829|PDB:5I9J"
FT   STRAND          340..342
FT                   /evidence="ECO:0007829|PDB:5I9J"
FT   STRAND          345..355
FT                   /evidence="ECO:0007829|PDB:5I9J"
FT   STRAND          357..366
FT                   /evidence="ECO:0007829|PDB:5I9J"
FT   STRAND          378..380
FT                   /evidence="ECO:0007829|PDB:5I9J"
FT   STRAND          385..392
FT                   /evidence="ECO:0007829|PDB:5I9J"
FT   STRAND          400..406
FT                   /evidence="ECO:0007829|PDB:5I9J"
FT   STRAND          412..414
FT                   /evidence="ECO:0007829|PDB:5I9J"
FT   HELIX           416..443
FT                   /evidence="ECO:0007829|PDB:5I9J"
SQ   SEQUENCE   445 AA;  50502 MW;  8EBFBAF013CFDC7E CRC64;
     MSKLPRELTR DLERSLPAVA SLGSSLSHSQ SLSSHLLPPP EKRRAISDVR RTFCLFVTFD
     LLFISLLWII ELNTNTGIRK NLEQEIIQYN FKTSFFDIFV LAFFRFSGLL LGYAVLRLRH
     WWVIAVTTLV SSAFLIVKVI LSELLSKGAF GYLLPIVSFV LAWLETWFLD FKVLPQEAEE
     ERWYLAAQVA VARGPLLFSG ALSEGQFYSP PESFAGSDNE SDEEVAGKKS FSAQEREYIR
     QGKEATAVVD QILAQEENWK FEKNNEYGDT VYTIEVPFHG KTFILKTFLP CPAELVYQEV
     ILQPERMVLW NKTVTACQIL QRVEDNTLIS YDVSAGAAGG VVSPRDFVNV RRIERRRDRY
     LSSGIATSHS AKPPTHKYVR GENGPGGFIV LKSASNPRVC TFVWILNTDL KGRLPRYLIH
     QSLAATMFEF AFHLRQRISE LGARA
//
